Terms: = Colorectal cancer AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463
28 results:
1. Artificial intelligence-driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi-center integration analysis.
Xu H; Liu Z; Weng S; Dang Q; Ge X; Zhang Y; Ren Y; Xing Z; Chen S; Zhou Y; Ren J; Han X
Mol Oncol; 2022 Dec; 16(22):4023-4042. PubMed ID: 36083778
[TBL] [Abstract] [Full Text] [Related]
2. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Bancroft EK; Page EC; Brook MN; Thomas S; Taylor N; Pope J; McHugh J; Jones AB; Karlsson Q; Merson S; Ong KR; Hoffman J; Huber C; Maehle L; Grindedal EM; Stormorken A; Evans DG; Rothwell J; Lalloo F; Brady AF; Bartlett M; Snape K; Hanson H; James P; McKinley J; Mascarenhas L; Syngal S; Ukaegbu C; Side L; Thomas T; Barwell J; Teixeira MR; Izatt L; Suri M; Macrae FA; Poplawski N; Chen-Shtoyerman R; Ahmed M; Musgrave H; Nicolai N; Greenhalgh L; Brewer C; Pachter N; Spigelman AD; Azzabi A; Helfand BT; Halliday D; Buys S; Ramon Y Cajal T; Donaldson A; Cooney KA; Harris M; McGrath J; Davidson R; Taylor A; Cooke P; Myhill K; Hogben M; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Dias A; Dudderidge T; Eccles DM; Green K; Eyfjord J; Falconer A; Foster CS; Gronberg H; Hamdy FC; Johannsson O; Khoo V; Lilja H; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra AV; Moynihan C; Ni Raghallaigh H; Rennert G; Collier R; ; Offman J; Kote-Jarai Z; Eeles RA
Lancet Oncol; 2021 Nov; 22(11):1618-1631. PubMed ID: 34678156
[TBL] [Abstract] [Full Text] [Related]
3. Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate cancer Cells In-Vitro.
Gupta A; Behl T; Heer HR; Deshmukh R; Sharma PL
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3341-3351. PubMed ID: 31759358
[TBL] [Abstract] [Full Text] [Related]
4. 20-Year Comparative Survival and Mortality of cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
5. Dynamic Changes in Circulating MicroRNA Levels in Liver cancer Patients Undergoing Thermal Ablation and Transarterial Chemoembolization.
Zavadil J; Juráček J; Čechová B; Andrašina T; Slabý O; Goldberg N
Klin Onkol; 2019; 32(Supplementum1):164-166. PubMed ID: 31064190
[TBL] [Abstract] [Full Text] [Related]
6. An experimental protocol for
Gonganau-Nitu D; Scurtu RR; Precup CG; Ciuce C
J Cancer Res Ther; 2019; 15(1):164-168. PubMed ID: 30880774
[TBL] [Abstract] [Full Text] [Related]
7. Re-assessing
Vedeld HM; Nesbakken A; Lothe RA; Lind GE
Clin Epigenetics; 2018; 10():70. PubMed ID: 29854011
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic impact of rita expression in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Steinhäuser K; Kreis NN; Friemel A; Martin D; Wieland U; Rave-Fränk M; Balermpas P; Fokas E; Louwen F; Rödel C; Yuan J
Radiother Oncol; 2018 Feb; 126(2):214-221. PubMed ID: 29122359
[TBL] [Abstract] [Full Text] [Related]
9. Methylation of znf331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth.
Wang Y; He T; Herman JG; Linghu E; Yang Y; Fuks F; Zhou F; Song L; Guo M
Clin Epigenetics; 2017; 9():115. PubMed ID: 29075358
[TBL] [Abstract] [Full Text] [Related]
10. Reactivating p53 and Inducing Tumor Apoptosis (rita) Enhances the Response of rita-Sensitive colorectal cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin.
Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C
Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059
[TBL] [Abstract] [Full Text] [Related]
11. Targeting NF-κB RelA/p65 phosphorylation overcomes rita resistance.
Bu Y; Cai G; Shen Y; Huang C; Zeng X; Cao Y; Cai C; Wang Y; Huang D; Liao DF; Cao D
Cancer Lett; 2016 Dec; 383(2):261-271. PubMed ID: 27721021
[TBL] [Abstract] [Full Text] [Related]
12. CRISPR-Cas9-based target validation for p53-reactivating model compounds.
Wanzel M; Vischedyk JB; Gittler MP; Gremke N; Seiz JR; Hefter M; Noack M; Savai R; Mernberger M; Charles JP; Schneikert J; Bretz AC; Nist A; Stiewe T
Nat Chem Biol; 2016 Jan; 12(1):22-8. PubMed ID: 26595461
[TBL] [Abstract] [Full Text] [Related]
13. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and znf331 are frequently methylated across gastrointestinal cancers.
Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
[TBL] [Abstract] [Full Text] [Related]
14. Laparoscopic left lateral sectionectomy with the use of Habib 4X: technical aspects.
Zacharoulis D; Sioka E; Tzovaras G; Jiao LR; Habib N
J Laparoendosc Adv Surg Tech A; 2013 Jun; 23(6):549-52. PubMed ID: 23621832
[TBL] [Abstract] [Full Text] [Related]
15. Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells.
Janouskova H; Ray AM; Noulet F; Lelong-Rebel I; Choulier L; Schaffner F; Lehmann M; Martin S; Teisinger J; Dontenwill M
Cancer Lett; 2013 Aug; 336(2):307-18. PubMed ID: 23523610
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1.
Ahmed A; Yang J; Maya-Mendoza A; Jackson DA; Ashcroft M
Cell Death Dis; 2011 May; 2(5):e160. PubMed ID: 21593792
[TBL] [Abstract] [Full Text] [Related]
17. Use of semiflexible applicators for radiofrequency ablation of liver tumors.
Gaffke G; Gebauer B; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
Cardiovasc Intervent Radiol; 2006; 29(2):270-5. PubMed ID: 16328685
[TBL] [Abstract] [Full Text] [Related]
18. [Potential advantages of the MRI for the radiofrequency ablation of liver tumors].
Gaffke G; Gebauer B; Gnauck M; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
Rofo; 2005 Jan; 177(1):77-83. PubMed ID: 15657824
[TBL] [Abstract] [Full Text] [Related]
19. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract] [Full Text] [Related]
20. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer.
King J; Glenn D; Clark W; Zhao J; Steinke K; Clingan P; Morris DL
Br J Surg; 2004 Feb; 91(2):217-23. PubMed ID: 14760671
[TBL] [Abstract] [Full Text] [Related]
[Next]
